Your browser doesn't support javascript.
loading
Multiple Hürthle cell adenomas in a patient with thyroid hormone resistance.
Xifra, Gemma; Mauri, Silvia; Gironès, Jordi; Rodríguez Hermosa, José Ignacio; Oriola, Josep; Ricart, Wifredo; Fernández-Real, José Manuel.
Afiliação
  • Xifra G; Department of Diabetes, Endocrinology and Nutrition Hospital Dr Josep Trueta Girona Spain.
  • Mauri S; Department of Diabetes, Endocrinology and Nutrition Hospital Dr Josep Trueta Girona Spain.
  • Gironès J; Department of Surgery Hospital Dr Josep Trueta Girona Spain.
  • Rodríguez Hermosa JI; Department of Surgery Hospital Dr Josep Trueta Girona Spain.
  • Oriola J; Biochemistry and Molecular Genetics Department CDB Hospital Clinic Barcelona Spain.
  • Ricart W; Department of Diabetes, Endocrinology and Nutrition Hospital Dr Josep Trueta Girona Spain.
  • Fernández-Real JM; Department of Diabetes, Endocrinology and Nutrition Hospital Dr Josep Trueta Girona Spain ; CIBERobn, patophysiology of obesity and nutrition Spain.
Article em En | MEDLINE | ID: mdl-24683474
ABSTRACT

BACKGROUND:

Thyroid hormone resistance (RTH) is a rare cause of thyroid dysfunction. High TSH levels, as described in RTH syndrome, are known to be associated with an increased risk of developing thyroid nodules with subsequent growth and malignancy. PATIENT

FINDINGS:

In 2006, a 29-year-old Caucasian man presented with a palpable mass in the neck. Increased free thyroxine and triiodothyronine levels were found in the context of unsuppressed TSH levels, despite no signs or symptoms of hyperthyroidism. Ultrasonography revealed a multinodular and enlarged goitre, and fine-needle aspiration cytology revealed suspicious features of malignancy. After excluding pituitary tumour and levothyroxine (l-T4) treatment, the patient was diagnosed with generalized RTH. Screening for all the known mutations in thyroid hormone receptor-ß (TR ß (THRB)) was negative. Thyroidectomy disclosed five Hürthle adenomas and three hyperplasic nodules. Euthyroidism was achieved after surgery with 6.1 µg/kg per day of l-T4.

CONCLUSION:

RTH may be a risk factor that predisposes to the development of multiple Hürthle cell adenomas. To our knowledge, this is the first case of multiple Hürthle cell adenomas in a patient with RTH. LEARNING POINTS High TSH levels, as described in RTH syndrome, are known to be associated with an increased risk of developing thyroid nodules, with subsequent growth and malignancy.The exact role of TR ß mutants in thyroid carcinogenesis is still undefined.We report the first case of multiple Hürthle cell adenomas associated with RTH.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2013 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2013 Tipo de documento: Article